Is Soy Isoflavones Bone Turnover Meta-Analysis safe?

The current Migaku evidence database contains 2 reusable source documents for Soy Isoflavones Bone Turnover Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts. - Results The combined EUE and Isf treatment significantly improved biomechanical performance of the femur and restored bone mineral content in ovariectomized rats. [Zhao R (2026); evidence level 4] - Levels of bone formation markers were elevated, whereas indices of bone resorption were reduced. [Zhao R (2026); evidence level 4] - In vitro , the combination enhanced osteoblast mineralization and proliferation, suppressed osteoclast formation, and increased osteoclast apoptosis. [Zhao R (2026); evidence level 4] - Background Postmenopausal osteoporosis (PMO) is driven by estrogen deficiency, enhanced osteoclastic activity, impaired osteoblast function, and persistent inflammatory signaling. [Zhao R (2026); evidence level 4] - This narrative review synthesizes mechanistic, translational, and clinical evidence to clarify the potential skeletal relevance of S-equol. [Sekikawa A (2025); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.